HelioLiver: Expanding Early Detection of Hepatocellular Carcinoma With AI

Read the full article at: Patients diagnosed with early-stage liver cancer have a significantly higher survival rate compared to those diagnosed in later stages, yet screening options and barriers persist. In the latest episode of Exploring AI in Oncology, Waqas Haque, MD, MPH, speaks with Bharat Tewarie, MD, MBA, the CEO of Helio Genomics, about the company’s AI-powered blood test, HelioLiver, and its potential role in detecting hepatocellular carcinoma (HCC), the most common form of liver cancer. Dr. Tewarie shares why liver cancer is a strong use case for blood-based early detection, how HelioLiver may fit into existing workflows, and barriers to overcome for broader adoption.

You can listen to HelioLiver: Expanding Early Detection of Hepatocellular Carcinoma With AI online on Radio and Podcast. Open the player on this page to stream the available audio.

HelioLiver: Expanding Early Detection of Hepatocellular Carcinoma With AI is an episode from Oncology Data Advisor by Oncology Data Advisor™.

This episode is 00:17:01 long.

This episode was published on Apr 15, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Data Advisor when more episodes are available from the podcast feed.